Alpha Receives NMPA Approval for Zorifertinib Tablets for Lung Cancer
20 Nov 2024 //
PR NEWSWIRE
Alpha Biopharma Submits New Drug Application for Zorifertinib
29 Jan 2023 //
PR NEWSWIRE
Alpha Biopharma Completes EVEREST PII/III Study of Zorifertinib in NSCLC
24 Aug 2022 //
PRNEWSWIRE